Related Experiment Video
Updated: May 22, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Association of platelet collagen receptor polymorphisms with premature acute myocardial infarction
Ahmad Kazemi1, Ahmad Fatemi, Nozar Givtaj
1Department of Hematology, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran.
Insights
This study found no link between specific platelet collagen receptor gene variations and heart attacks in young adults. Genetic factors like GP VI T13254C and GP Ia C807T do not appear to increase the risk of premature myocardial infarction.
Area of Science:
- Cardiovascular Genetics
- Molecular Medicine
- Platelet Biology
Background:
- Platelet collagen receptors play a role in thrombosis.
- Genetic variations in these receptors may influence cardiovascular disease risk.
- The association of specific polymorphisms with premature myocardial infarction is not well understood.
Purpose of the Study:
- To investigate the association between platelet collagen receptor gene polymorphisms (GP VI T13254C and GP Ia C807T) and premature acute myocardial infarction.
- To determine if these genetic variations are risk factors for early-onset heart attacks.
Main Methods:
- Case-control study involving 100 patients with premature acute myocardial infarction and 100 age-matched controls.
- Genotyping performed using Polymerase Chain Reaction (PCR) and Restriction Fragment Length Polymorphism (RFLP).
- Statistical analysis including logistic regression to assess associations.
Main Results:
- The GP Ia C807T polymorphism was more frequent in patients (65%) than controls (53%), but this difference was not statistically significant (P = 0.08).
- The GP VI T13254C polymorphism prevalence was similar between patients (38%) and controls (33%), with no significant association (P = 0.46).
- Logistic regression confirmed no significant association for either polymorphism with premature acute myocardial infarction.
Conclusions:
- Neither the GP VI T13254C nor the GP Ia C807T polymorphisms are associated with premature acute myocardial infarction.
- These specific genetic variations in platelet collagen receptors do not appear to be risk factors for early-onset heart attacks.
Abstract:
The impact of platelet collagen receptor polymorphisms in the pathogenesis of myocardial infarction at young age remains unknown. To determine whether either of the two platelet collagen receptor polymorphisms (GP VI T13254C and GP Ia C807T) was associated with premature acute myocardial infarction. One hundred patients with premature acute myocardial infarction and 100 age-matched controls with normal coronary angiograms were studied. Genotyping was done using PCR followed by restriction fragment length polymorphism (RFLP). GP Ia C807T polymorphism was more frequent in the patient group (65%) than in the control group (53%). However, there was no association between this polymorphism and premature acute myocardial infarction (P = 0.08). The prevalence of T13254C polymorphism did not differ between patients (38%) and controls (33%), and this polymorphism was not associated with premature acute myocardial infarction (P = 0.46). Logistic regression analysis also indicated no association between these polymorphisms and premature acute myocardial infarction (C807T with P = 0.51 and T13254C with P = 0.20). There is no association between GP VI T13254C or GP Ia C807T polymorphisms and premature acute myocardial infarction.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Atherosclerosis I: Introduction
Peripheral Artery Disease I: Introduction

